Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.01M Buy
+402,840
New +$7.14M 0.02% 635
2016
Q3
– Sell
-6,524
Closed -$129K – 1341
2016
Q2
$129K Sell
6,524
-12,588
-66% -$214K ﹤0.01% 867
2016
Q1
$324K Sell
19,112
-1,852
-9% -$30.9K ﹤0.01% 788
2015
Q4
$429K Buy
20,964
+2,472
+13% +$51.4K ﹤0.01% 762
2015
Q3
$397K Buy
18,492
+17,048
+1,181% +$380K ﹤0.01% 740
2015
Q2
$29K Sell
1,444
-52
-3% -$913 ﹤0.01% 1142
2015
Q1
$23K Buy
1,496
+864
+137% +$13.1K ﹤0.01% 1171
2014
Q4
$9K Buy
+632
New +$7.74K ﹤0.01% 1274
2014
Q2
– Sell
-28,696
Closed -$297K – 1297
2014
Q1
$297K Buy
+28,696
New +$297K ﹤0.01% 860

Other funds holding DXCM

BlackRock Japan's DXCM Position: Q4 2016 in Review

BlackRock Japan opened a new position in DexCom (DXCM) in Q4 2016: 402,840 shares worth $6.01M. The stake represents 0.02% of the portfolio and ranks #635 among its holdings. This is a return to the name: BlackRock Japan previously reported a position in DXCM as recently as Q2 2016.

BlackRock Japan first reported a position in DXCM in Q1 2014 and has held it in 9 quarters since. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

  • BlackRock Japan held 402,840 shares of DexCom worth $6.01M as of Q4 2016.
  • DexCom was a new BlackRock Japan position in Q4 2016.
  • DexCom made up 0.02% of BlackRock Japan's portfolio in Q4 2016, its #635 holding.
  • BlackRock Japan first reported a position in DexCom in Q1 2014 and has held it in 9 quarters since.
  • 316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.